Natco Pharma unveils additional strengths of generic Revlimid in U.S.
A bottle of Revlimid seen at a store in Utah. File photo | Photo Credit: Reuters Natco Pharma has launched its generic version of Celgene Corporation’s cancer drug Revlimid (lenalidomide capsules) in additional strengths in the United States. The 2.5 mg and 20 mg strengths of the prescription medicine used in adults for the treatment […]
Continue Reading
